🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT06207903
Starting soon Observational

Navigating the Clinical Research Process for Mild Cognitive Impairment

NCT06207903 · tracked via the Priya Life Science USA tracker
Sponsor
Power Life Sciences Inc.
Phase
Observational
Started
2025-02
Last updated
2024-01-17

Condition(s) studied

Mild Cognitive Impairment

Study summary

Participation in medical research usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups.

This trial will admit a wide range of data on the clinical trial experience of mild cognitive impairment patients to determine which factors prevail in limiting a patient's ability to join or finish a trial.

It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future mild cognitive impairment patients.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: * Confirmed diagnosis of mild cognitive impairment * Participant must be 18 years of age or older * Participant must be willing and able to comply with scheduled visits, treatment schedule, laboratory tests, and other requirements of the study. Exclusion Criteria: * Pregnant or lactating woman * Participant is actively receiving study therapy in another * Inability to provide written informed consent

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Power Life Sciences San Francisco California

More Power Life Sciences Inc. trials in the USA

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06207903 on ClinicalTrials.gov ↗ ← All trials in the USA